UBS Maintains Neutral on ArcBest, Raises Price Target to $145

ArcBest Corporation

ArcBest Corporation

ARCB

0.00

UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ: ARCB) with a Neutral and raises the price target from $122 to $145.